{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:32:01Z","timestamp":1790386321592,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.imbio.2019.07.002","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T19:39:33Z","timestamp":1565379573000},"page":"649-658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["TGF-\u03b2 regulated leukemia cell susceptibility against NK targeting through the down-regulation of the CD48 expression"],"prefix":"10.1016","volume":"224","author":[{"given":"Chin-Han","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jen","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzeon-Jye","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hsi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuh-Ching","family":"Twu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2019.07.002_bib0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGFbeta in Cancer","volume":"134","author":"Massague","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2019.07.002_bib0010","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1073\/pnas.1633291100","article-title":"The two faces of transforming growth factor beta in carcinogenesis","volume":"100","author":"Roberts","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2019.07.002_bib0015","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.4161\/cc.8.20.9727","article-title":"Gain or loss of TGFbeta signaling in mammary carcinoma cells can promote metastasis","volume":"8","author":"Bierie","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.imbio.2019.07.002_bib0020","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by TGFbeta","volume":"10","author":"Flavell","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1074-7613(00)80170-3","article-title":"Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease","volume":"12","author":"Gorelik","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2019.07.002_bib0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ccr.2006.11.023","article-title":"High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene","volume":"11","author":"Arias","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.imbio.2019.07.002_bib0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-beta regulation of immune responses","volume":"24","author":"Li","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0040","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm1001-1118","article-title":"Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells","volume":"7","author":"Gorelik","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.imbio.2019.07.002_bib0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance","volume":"8","author":"Thomas","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.imbio.2019.07.002_bib0050","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ccr.2005.10.018","article-title":"The dual adverse effects of TGF-beta secretion on tumor progression","volume":"8","author":"Trapani","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.imbio.2019.07.002_bib0055","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1084\/jem.194.5.629","article-title":"Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta","volume":"194","author":"Nakamura","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2019.07.002_bib0060","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.20051511","article-title":"CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner","volume":"202","author":"Ghiringhelli","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2019.07.002_bib0065","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.immuni.2009.04.010","article-title":"Mechanisms of foxp3+ T regulatory cell-mediated suppression","volume":"30","author":"Shevach","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2019.07.002_bib0070","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.4049\/jimmunol.146.11.4016","article-title":"Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA","volume":"146","author":"Kehrl","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0075","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1074-7613(00)00044-3","article-title":"TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo","volume":"13","author":"Cazac","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2019.07.002_bib0080","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.0730640100","article-title":"Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells","volume":"100","author":"Castriconi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2019.07.002_bib0085","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.4049\/jimmunol.172.12.7335","article-title":"Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients","volume":"172","author":"Lee","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0090","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.imbio.2019.07.002_bib0095","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1172\/JCI19540","article-title":"TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia","volume":"113","author":"Hilgarth","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2019.07.002_bib0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/(SICI)1096-8652(199810)59:2<133::AID-AJH6>3.0.CO;2-Z","article-title":"Systemic transforming growth factor-beta in patients with bone marrow fibrosis--pathophysiological implications","volume":"59","author":"Rameshwar","year":"1998","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0105","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia","volume":"463","author":"Naka","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2019.07.002_bib0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: natural killer cell activation and inhibition","volume":"9","author":"Lanier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0115","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2741\/2735","article-title":"Regulation of NK cell activity by 2B4, NTB-A and CRACC","volume":"13","author":"Claus","year":"2008","journal-title":"Front Biosci."},{"key":"10.1016\/j.imbio.2019.07.002_bib0120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0092-8674(82)90239-2","article-title":"Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts","volume":"30","author":"Thorley-Lawson","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2019.07.002_bib0125","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.4049\/jimmunol.146.7.2192","article-title":"Expression of the Blast-1 activation\/adhesion molecule and its identification as CD48","volume":"146","author":"Yokoyama","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0130","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1442-200X.1998.tb01994.x","article-title":"CD48 expression on leukocytes in infectious diseases: flow cytometric analysis of surface antigen","volume":"40","author":"Katsuura","year":"1998","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.imbio.2019.07.002_bib0135","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.molimm.2004.07.021","article-title":"2B4 co-stimulation: NK cells and their control of adaptive immune responses","volume":"42","author":"Assarsson","year":"2005","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0140","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1034\/j.1600-065X.2001.1810120.x","article-title":"2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes","volume":"181","author":"Boles","year":"2001","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imbio.2019.07.002_bib0145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S1074-7613(00)80644-5","article-title":"Engagement of GPI-linked CD48 contributes to TCR signals and cytoskeletal reorganization: a role for lipid rafts in T cell activation","volume":"9","author":"Moran","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2019.07.002_bib0150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/107999003321455462","article-title":"CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition\/adhesion, and cytotoxicity","volume":"23","author":"Musgrave","year":"2003","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.imbio.2019.07.002_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2004.06.006","article-title":"CD2-CD48 interactions promote interleukin-2 and interferon-gamma synthesis by stabilizing cytokine mRNA","volume":"229","author":"Musgrave","year":"2004","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0160","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/intimm\/6.5.701","article-title":"Anti-CD48 (murine CD2 ligand) mAbs suppress cell mediated immunity in vivo","volume":"6","author":"Chavin","year":"1994","journal-title":"Int. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0165","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.4049\/jimmunol.176.8.4646","article-title":"CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells","volume":"176","author":"Messmer","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0170","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1164\/rccm.200605-695OC","article-title":"CD48 is critically involved in allergic eosinophilic airway inflammation","volume":"175","author":"Munitz","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.imbio.2019.07.002_bib0175","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1128\/IAI.00270-08","article-title":"Human mast cell activation by Staphylococcus aureus: interleukin-8 and tumor necrosis factor alpha release and the role of Toll-like receptor 2 and CD48 molecules","volume":"76","author":"Rocha-de-Souza","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.imbio.2019.07.002_bib0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4049\/jimmunol.177.1.77","article-title":"CD48 is an allergen and IL-3-induced activation molecule on eosinophils","volume":"177","author":"Munitz","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0185","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2019.07.002_bib0190","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.immunol.25.022106.141618","article-title":"Structural basis of integrin regulation and signaling","volume":"25","author":"Luo","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0195","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1182\/blood-2009-01-201632","article-title":"Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors","volume":"114","author":"Bryceson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2019.07.002_bib0200","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.4049\/jimmunol.178.3.1261","article-title":"Activating Ly-49 receptors regulate LFA-1-mediated adhesion by NK cells","volume":"178","author":"Osman","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0205","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/eji.201344272","article-title":"Effect of tumor cells and tumor microenvironment on NK-cell function","volume":"44","author":"Vitale","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","article-title":"Natural innate and adaptive immunity to cancer","volume":"29","author":"Vesely","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0215","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri1936","article-title":"Cancer despite immunosurveillance: immunoselection and immunosubversion","volume":"6","author":"Zitvogel","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0220","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3324\/haematol.2013.087536","article-title":"Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia","volume":"99","author":"Stringaris","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.imbio.2019.07.002_bib0225","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1038\/onc.2008.267","article-title":"NK cells and cancer immunosurveillance","volume":"27","author":"Waldhauer","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.imbio.2019.07.002_bib0230","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nri2604","article-title":"Oncogenic stress sensed by the immune system: role of natural killer cell receptors","volume":"9","author":"Raulet","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0235","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood-2005-08-027979","article-title":"Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction","volume":"109","author":"Arnoulet","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2019.07.002_bib0240","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2853","article-title":"TGFbeta signalling: a complex web in cancer progression","volume":"10","author":"Ikushima","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.imbio.2019.07.002_bib0245","doi-asserted-by":"crossref","first-page":"7596","DOI":"10.1158\/0008-5472.CAN-04-1627","article-title":"RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo","volume":"64","author":"Friese","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.imbio.2019.07.002_bib0250","first-page":"19","article-title":"A developed NK-92MI cell line with Siglec-7(neg) phenotype exhibits high and sustainable cytotoxicity against leukemia cells","author":"Huang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imbio.2019.07.002_bib0255","first-page":"1040","volume":"57","author":"Y-HL","year":"2017"},{"key":"10.1016\/j.imbio.2019.07.002_bib0260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jim.2005.12.005","article-title":"A novel flow-cytometry-based assay for quantification of affinity and avidity changes of integrins","volume":"310","author":"Konstandin","year":"2006","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.imbio.2019.07.002_bib0265","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.4049\/jimmunol.1601004","article-title":"LFA-1 activation in NK cells and their subsets: influence of receptors, maturation, and cytokine stimulation","volume":"198","author":"Urlaub","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0270","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O","article-title":"Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma","volume":"91","author":"Kanehira","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.imbio.2019.07.002_bib0275","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0169-5002(96)00611-3","article-title":"Plasma transforming growth factor-beta 1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor marker","volume":"16","author":"Kong","year":"1996","journal-title":"Lung Cancer"},{"key":"10.1016\/j.imbio.2019.07.002_bib0280","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ijc.1631","article-title":"Significance of transforming growth factor beta1 as a new tumor marker for colorectal cancer","volume":"97","author":"Narai","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.imbio.2019.07.002_bib0285","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1089\/15258160152509145","article-title":"Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92","volume":"10","author":"Tonn","year":"2001","journal-title":"J. Hematother. Stem Cell Res."},{"key":"10.1016\/j.imbio.2019.07.002_bib0290","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jcyt.2013.06.017","article-title":"Treatment of patients with advanced cancer with the natural killer cell line NK-92","volume":"15","author":"Tonn","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.imbio.2019.07.002_bib0295","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/14653240802301872","article-title":"Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial","volume":"10","author":"Arai","year":"2008","journal-title":"Cytotherapy"},{"key":"10.1016\/j.imbio.2019.07.002_bib0300","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1158\/0008-5472.CAN-11-0414","article-title":"Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling","volume":"71","author":"Zhang","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.imbio.2019.07.002_bib0305","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imbio.2019.07.002_bib0310","doi-asserted-by":"crossref","first-page":"34414","DOI":"10.1074\/jbc.M804756200","article-title":"Nanoscale increases in CD2-CD48-mediated intermembrane spacing decrease adhesion and reorganize the immunological synapse","volume":"283","author":"Milstein","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2019.07.002_bib0315","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1073\/pnas.96.3.1019","article-title":"CD48-deficient mice have a pronounced defect in CD4(+) T cell activation","volume":"96","author":"Gonzalez-Cabrero","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2019.07.002_bib0320","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood-2013-09-526590","article-title":"Immune evasion by oncogenic proteins of acute myeloid leukemia","volume":"123","author":"Elias","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2019.07.002_bib0325","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.20051143","article-title":"Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells","volume":"202","author":"Bryceson","year":"2005","journal-title":"J. Exp. Med."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298519301020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298519301020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:45:41Z","timestamp":1759250741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298519301020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0171298519301020"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2019.07.002","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TGF-\u03b2 regulated leukemia cell susceptibility against NK targeting through the down-regulation of the CD48 expression","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2019.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}